VentriPoint Diagnostics Ltd
- Country
- Ownership
- -
- Employees
- -
- Market Cap
- -
- Introduction
VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It develops applications for heart diseases and imaging modalities which includes congenital heart disease, left or right heart failure, and normal hearts. It sells its products in Canada and internationally.
Clinical Trials
2
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Assessmet of Patients With PAH Right Ventricular Volume
- Conditions
- Pulmonary Arterial Hypertension
- First Posted Date
- 2012-03-19
- Last Posted Date
- 2015-03-27
- Lead Sponsor
- VentriPoint Diagnostics Ltd.
- Target Recruit Count
- 103
- Registration Number
- NCT01557582
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
Assessment of Right Ventricular Volume in Tetralogy of Fallott (TOF) Patients
- Conditions
- Tetralogy of Fallot
- First Posted Date
- 2011-08-18
- Last Posted Date
- 2014-10-06
- Lead Sponsor
- VentriPoint Diagnostics Ltd.
- Target Recruit Count
- 109
- Registration Number
- NCT01419756
- Locations
- 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States
🇺🇸University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States